Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-034969
Filing Date
2025-03-06
Accepted
2025-03-06 17:55:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 6790
  Complete submission text file 0000950170-25-034969.txt   8524
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Subject) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-83932 | Film No.: 25716647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AADI BIOSCIENCE, INC. 17383 SUNSET BLVD., SUITE A250 PACIFIC PALISADES CA 90272
Business Address
Desai Neil (Filed by) CIK: 0001878692 (see all company filings)

Type: SCHEDULE 13D/A